Consistent with our findings, investigations on patients with lymphoepithelioma-like carcinoma of the thymus have also revealed the absence of actionable genes as well as the detection of various degrees of membranous PD-L1 staining in their cohort (total: 71.4%, 15/21; high expression (>50% of tumor cells): 48%; low expression (<50% of tumor cells): 25%) [51, 52]. The gene discussed is CD274; the disease is thymic carcinoma.